CANF - Can-Fite BioPharma Stock Price, News & Analysis

$1.43 0.02 (1.42 %)
(As of 11/24/2017 11:27 AM ET)
Previous Close$1.41
Today's Range$1.37 - $1.44
52-Week Range$1.31 - $2.67
Volume47,300 shs
Average Volume58,894 shs
Market Capitalization$24.54 million
P/E RatioN/A
Dividend YieldN/A

About Can-Fite BioPharma (NYSEAMERICAN:CANF)

Can-Fite BioPharma logoCan Fite Biofarma Ltd is an Israel-based biopharmaceutical company. The Company develops new treatments for autoimmune diseases and cancer. The Company’s drugs are CF101 for Psoriasis treatment, RA treatment, for the treatment of Keratoconjunctictivitis Sicca, for the treatment of Glaucoma, among others; and CF102 for the treatment of liver diseases. The Company has a research infrastructure including research laboratories and animal house facilities run by the development team. Can Fite Biofarma Ltd signed distribution contracts with a Kwang Dong Pharmaceutical Co. allowing distribution of CF101 for arthritis in Korea and Seikagaku Corp. for distribution in Japan. The Company operates three subsidiaries, Ultratrend Ltd, EyeFite Ltd and OphathaliX Inc.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research


Debt-to-Equity RatioN/A
Current Ratio7.29%
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Annual DividendN/A
Dividend YieldN/A


Trailing EPS$0.25
Net IncomeN/A
Net Margins-2,453.03%
Return on Equity-57.94%
Return on Assets-32.52%


Outstanding Shares16,580,000

Frequently Asked Questions for Can-Fite BioPharma (NYSEAMERICAN:CANF)

What is Can-Fite BioPharma's stock symbol?

Can-Fite BioPharma trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CANF."

How were Can-Fite BioPharma's earnings last quarter?

Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF) released its quarterly earnings results on Tuesday, May, 31st. The biotechnology company reported ($0.12) earnings per share for the quarter, missing analysts' consensus estimates of ($0.09) by $0.03. Can-Fite BioPharma had a negative net margin of 2,453.03% and a negative return on equity of 57.94%. View Can-Fite BioPharma's Earnings History.

When will Can-Fite BioPharma make its next earnings announcement?

Can-Fite BioPharma is scheduled to release their next quarterly earnings announcement on Friday, November, 24th 2017. View Earnings Estimates for Can-Fite BioPharma.

Where is Can-Fite BioPharma's stock going? Where will Can-Fite BioPharma's stock price be in 2017?

2 brokers have issued 1-year target prices for Can-Fite BioPharma's shares. Their predictions range from $6.00 to $7.00. On average, they expect Can-Fite BioPharma's stock price to reach $6.50 in the next twelve months. View Analyst Ratings for Can-Fite BioPharma.

Who are some of Can-Fite BioPharma's key competitors?

Who are Can-Fite BioPharma's key executives?

Can-Fite BioPharma's management team includes the folowing people:

  • Ilan Cohen, Chairman of the Board (Age 61)
  • Pnina Fishman Ph.D., Chief Executive Officer, Director (Age 67)
  • Motti Farbstein, Chief Financial Officer, Chief Operating Officer (Age 51)
  • Guy Regev, Director (Age 47)
  • Abraham Sartani M.D., Director (Age 68)
  • Israel Shamay, External Director (Age 51)

How do I buy Can-Fite BioPharma stock?

Shares of Can-Fite BioPharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Can-Fite BioPharma's stock price today?

One share of Can-Fite BioPharma stock can currently be purchased for approximately $1.43.

How big of a company is Can-Fite BioPharma?

Can-Fite BioPharma has a market capitalization of $24.54 million. Can-Fite BioPharma employs 7 workers across the globe.

How can I contact Can-Fite BioPharma?

Can-Fite BioPharma's mailing address is 10 Bareket Street, Kiryat Matalon P.O. Box 7537, PETAH TIKVA, 49170, Israel. The biotechnology company can be reached via phone at +972-3-9241114.

MarketBeat Community Rating for Can-Fite BioPharma (CANF)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  72 (Vote Outperform)
Underperform Votes:  47 (Vote Underperform)
Total Votes:  119
MarketBeat's community ratings are surveys of what our community members think about Can-Fite BioPharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Can-Fite BioPharma (NYSEAMERICAN:CANF)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 2 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.50

Consensus Price Target History for Can-Fite BioPharma (NYSEAMERICAN:CANF)

Price Target History for Can-Fite BioPharma (NYSEAMERICAN:CANF)

Analysts' Ratings History for Can-Fite BioPharma (NYSEAMERICAN:CANF)

DateFirmActionRatingPrice TargetDetails
10/31/2017HC WainwrightReiterated RatingBuyView Rating Details
10/30/2017Maxim GroupSet Price TargetBuy$7.00View Rating Details
10/18/2016Roth CapitalReiterated RatingBuyView Rating Details
8/29/2016Rodman & RenshawInitiated CoverageBuy$6.00View Rating Details
(Data available from 11/24/2015 forward)


Earnings History and Estimates Chart for Can-Fite BioPharma (NYSEAMERICAN:CANF)

Earnings by Quarter for Can-Fite BioPharma (NYSEAMERICAN:CANF)

Earnings History by Quarter for Can-Fite BioPharma (NYSEAMERICAN CANF)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/31/2016Q116($0.09)($0.12)ViewN/AView Earnings Details
5/29/2015Q115($0.12)($0.04)ViewN/AView Earnings Details
4/8/2015($0.15)($0.20)ViewN/AView Earnings Details
12/2/2014($0.24)($0.10)ViewN/AView Earnings Details
9/3/2014($0.36)($0.20)ViewN/AView Earnings Details
5/30/2014($0.23)($0.22)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Can-Fite BioPharma (NYSEAMERICAN:CANF)

No earnings estimates for this company have been tracked by


Dividend History for Can-Fite BioPharma (NYSEAMERICAN:CANF)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Can-Fite BioPharma (NYSEAMERICAN CANF)
No insider trades for this company have been tracked by


Latest Headlines for Can-Fite BioPharma (NYSEAMERICAN CANF)


Social Media

Social activity is not available for this stock.


Financials are not available for this stock.


Can-Fite BioPharma (NYSEAMERICAN CANF) Chart for Friday, November, 24, 2017
Loading chart…

This page was last updated on 11/24/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.